CELC
Price
$93.53
Change
+$2.96 (+3.27%)
Updated
Aug 21 closing price
Capitalization
4.58B
87 days until earnings call
Intraday BUY SELL Signals
NRXS
Price
$6.15
Change
-$0.12 (-1.91%)
Updated
Aug 21 closing price
Capitalization
77.23M
25 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CELC vs NRXS

CELC vs NRXS Comparison Chart in %
View a ticker or compare two or three
VS
CELC vs. NRXS commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Hold and NRXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (CELC: $93.53 vs. NRXS: $6.15)
Brand notoriety: CELC and NRXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 49% vs. NRXS: 109%
Market capitalization -- CELC: $4.58B vs. NRXS: $77.23M
CELC [@Biotechnology] is valued at $4.58B. NRXS’s [@Biotechnology] market capitalization is $77.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green whileNRXS’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • NRXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both CELC and NRXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 3 TA indicator(s) are bullish while NRXS’s TA Score has 3 bullish TA indicator(s).

  • CELC’s TA Score: 3 bullish, 4 bearish.
  • NRXS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CELC is a better buy in the short-term than NRXS.

Price Growth

CELC (@Biotechnology) experienced а +1.66% price change this week, while NRXS (@Biotechnology) price change was -2.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

CELC is expected to report earnings on Nov 18, 2026.

NRXS is expected to report earnings on Sep 17, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($4.58B) has a higher market cap than NRXS($77.2M). NRXS YTD gains are higher at: 35.463 vs. CELC (-6.226). NRXS has higher annual earnings (EBITDA): -7.12M vs. CELC (-172.66M). CELC has more cash in the bank: 387M vs. NRXS (7.08M). NRXS has less debt than CELC: NRXS (354K) vs CELC (323M). NRXS has higher revenues than CELC: NRXS (4.28M) vs CELC (0).
CELCNRXSCELC / NRXS
Capitalization4.58B77.2M5,929%
EBITDA-172.66M-7.12M2,426%
Gain YTD-6.22635.463-18%
P/E RatioN/AN/A-
Revenue04.28M-
Total Cash387M7.08M5,467%
Total Debt323M354K91,243%
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
43
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELCNRXS
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 10 days ago
85%
Declines
ODDS (%)
Bearish Trend 13 days ago
84%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CELC
Daily Signal:
Gain/Loss:
NRXS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UBPSX24.881.07
+4.49%
ProFunds UltraLatin America Svc
GOFCX24.740.35
+1.44%
Victory Pioneer Select Mid Cap Growth C
COSYX15.190.21
+1.40%
Columbia Overseas Value Inst3
IHSSX33.190.17
+0.51%
Hartford Small Company R4
CRVRX9.16-0.01
-0.11%
NYLI CBRE Real Estate Fund Investor Cl

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been closely correlated with IMA. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CELC jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
+3.27%
IMA - CELC
76%
Closely correlated
-3.16%
SLXN - CELC
50%
Loosely correlated
-1.23%
ABOS - CELC
44%
Loosely correlated
-0.94%
ANRO - CELC
39%
Loosely correlated
+0.09%
GLSI - CELC
39%
Loosely correlated
+8.88%
More

NRXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
-1.91%
CVM - NRXS
58%
Loosely correlated
-2.74%
ANRO - NRXS
29%
Poorly correlated
+0.09%
PVLA - NRXS
28%
Poorly correlated
-0.38%
NTLA - NRXS
27%
Poorly correlated
+3.22%
CELC - NRXS
26%
Poorly correlated
+3.27%
More